Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Jumia Nigeria: from Retail to Marketplace (A) and (B), Teaching Note
Casadesus-Masanell, Ramon; Elterman, KarenNota del Instructor HBS-718467-EDirección estratégicaTeaching note for cases 718401 and 718432.Desde 0,00 €
-
Imprimis (B)
Casadesus-Masanell, Ramon; Elterman, Karen; Appel, MarcCaso HBS-717496-EIniciativa emprendedoraThis case is a supplement to Imprimis (Case A). It describes the company's decision to enter into the pharmaceutical compounding business in 2013-14. Imprimis purchased a compounded ophthalmological medication called Dropless Therapy, which was injected into patients' eyes post-cataract surgery, with the aim of replacing a complex regimen of prescription eye drops. After a successful launch of the compounded medication, Imprimis ran into complica...Desde 5,74 €
-
Imprimis (A)
Casadesus-Masanell, Ramon; Elterman, Karen; Appel, MarcCaso HBS-717426-EIniciativa emprendedoraThis case examines the strategic choices and evolving business model of Imprimis Pharmaceuticals from the perspective of CEO Mark Baum. The A case provides a brief history of the company and of the compounding business, outlining the challenges faced by Imprimis in 2013. At the time, Imprimis was in the process of seeking FDA approval for a branded drug called Impracor. This process, already difficult, was further complicated by recent manufactur...Desde 8,20 €
-
Imprimis (D)
Casadesus-Masanell, Ramon; Elterman, Karen; Appel, MarcCaso HBS-717498-EIniciativa emprendedoraThis case is a supplement to Imprimis (Case A), Imprimis (Case B), and Imprimis (Case C). It describes Imprimis's 2015 decision to develop a $1 per pill compounded alternative to Daraprim, the branded drug that had recently undergone an extreme price hike, raising its price to $750/pill. Imprimis also created compounded alternatives to several other branded drugs, and made investments to increase its manufacturing capabilities. The company now ha...Desde 5,74 €
-
Imprimis (C)
Casadesus-Masanell, Ramon; Elterman, Karen; Appel, MarcCaso HBS-717497-EIniciativa emprendedoraThis case is a supplement to Imprimis (Case A) and Imprimis (Case B). Set in 2015, it first describes Imprimis's decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the problem of high drug prices in the United States. Recent, drastic price hikes on pharmaceutical drugs, such as those initiated by Turing Pharmaceuticals under CEO ...Desde 5,74 €
-
KITEA (A) - (F), Teaching Note
Casadesus-Masanell, Ramon; Elterman, KarenNota del Instructor HBS-719490-EDirección estratégicaThis teaching note accompanies the KITEA series of cases, which details how the Moroccan furniture company KITEA prepared for the entry of IKEA into the Moroccan market and describes the outcome of that entry.Desde 0,00 €
-
Walmart Ecommerce (B): Omnichannel Pursuits
Casadesus-Masanell, Ramon; Elterman, KarenCaso HBS-720426-EDirección estratégicaThis case is an abridged version (part 2 of 2) of "Walmart's Omnichannel Strategy: Revolution or Miscalculation?", HBS Case 720-370. The (B) case describes Walmart's omnichannel strategy in 2018 as it battled Amazon for online retail market share. Walmart aimed to integrate its enormous brick and mortar footprint with its growing ecommerce business, e.g., through merchandise and grocery delivery and order online, pickup in store options. It a...Desde 5,74 €
-
Luckin Coffee (B): Revelations of Fraud
Casadesus-Masanell, Ramon; Elterman, KarenCaso HBS-721371-EDirección estratégicaThis case describes revelations of fraud at Luckin Coffee, beginning with an anonymous report in January 2020 and continuing with the company's admission in April 2020 that it had inflated its revenues by 2.2 billion RMB ($310 million), almost half its reported revenue, in the last three quarters of 2019. It was later found that Luckin had arranged false transactions at many of its stores, and that it had sold tens of millions of cups of coffee (...Desde 5,74 €
-
Sportradar (A): From Data to Storytelling
Casadesus-Masanell, Ramon; Elterman, Karen; Gassmann, OliverCaso HBS-719429-EDirección estratégicaIn 2013, the Swiss sports data company Sportradar debated whether to expand from its core business of data provision to bookmakers into sports media products. Sports data was becoming a commodity, and in the future, sports leagues might reduce their dependence on third-party data feeds such as Sportradar's, prefering to develop data services in-house. Thus, CEO Carsten Koerl believed the company needed to branch into sports media, not just supply...Desde 8,20 €
-
The Rise and Fall of the Circus
Casadesus-Masanell, Ramon; Elterman, KarenCaso HBS-717444-EDirección estratégicaThis case describes the origins of the traditional circus, including its rise to popularity in the United States in the 1800s, and examines the factors that led to its decline in the 20th and 21st centuries.Desde 8,20 €